NCT00834288View on ClinicalTrials.gov

A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

August 31, 2003

Conditions
Healthy SubjectsPharmacokineticsBioavailability
Interventions
DRUG

Tramadol HCl

1x200 mg Tramadol HCl OAD tablet daily

DRUG

Tramadol HCl

1x50 mg Tramadol HCl IR (Ultram®) tablet 6-hourly

Sponsors

Lead Sponsor

Labopharm Inc.
All Listed Sponsors
lead

Labopharm Inc.

INDUSTRY